Triall today announces that Nick van den Bulk has joined the initiative as advisor Clinical Operations.
Nick was trained as a biopharmaceutical scientist at the University of Leiden (MSc) and currently is Head Clinical Operations at CR2O, a Dutch full-service contract research organization for clinical trial operations. He oversees several large international clinical trials funded by CEPI and Horizon 2020. Through various previous roles in the clinical trial industry, Nick gained experience in a variety of therapeutic areas, including oncology, auto-immune diseases, and gene therapy.
Nick will leverage his vast experience in clinical operations to support Triall in drafting and translating user demands into concrete product features.